A novel combined radiological method for evaluation of the response to chemotherapy for primary bone sarcoma

Journal of Surgical Oncology

Volumn 106, Issue 3, 2012, Pages 273-279

  Miwa, Shinji ^a   Taki, Junichi ^a   Yamamoto, Norio ^a   Shirai, Toshiharu ^a   Nishida, Hideji ^a   Hayashi, Katsuhiro ^a   Tanzawa, Yoshikazu ^a   Kimura, Hiroaki ^a   Takeuchi, Akihiko ^a   Igarashi, Kentaro ^a   Ooi, Akishi ^a   Tsuchiya, Hiroyuki ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

accuracy; bone sarcoma; chemotherapy; histology; radiology

Indexed keywords

CISPLATIN; DOXORUBICIN; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADOLESCENT; ADULT; AGED; ANGIOGRAPHY; ARTICLE; BONE NECROSIS; BONE RADIOGRAPHY; BONE SCINTISCANNING; CANCER CHEMOTHERAPY; CANCER SURGERY; CHILD; CHONDROSARCOMA; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTINUOUS INFUSION; EWING SARCOMA; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; PLEOMORPHIC SARCOMA; PREOPERATIVE PERIOD; PRESCHOOL CHILD; PRIMARY TUMOR; PRIORITY JOURNAL; SARCOMA; SCHOOL CHILD; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; CISPLATIN; DIAGNOSTIC IMAGING; DOXORUBICIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SARCOMA; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84864678048     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23074     Document Type: Article

References (37)

1. Tsuchiya H, Tomita K, Minematsu K, et al.: Limb salvage using distraction osteogenesis. A classification of the technique. J Bone Joint Surg [Br] 1997; 79: 403-411.
2. Tsuchiya H, Tomita K, Mori Y, et al.: Marginal excision for osteosarcoma with caffeine assisted chemotherapy. Clin Orhop Res 1999; 358: 27-35.
3. Tsuchiya H, Nishida H, Srisawat P, et al.: Pedicle frozen autograft reconstruction in malignant bone tumors. J Orthop Sci 2010; 15: 340-349.
4. Manabe J, Ahmed AR, Kawaguchi N, et al.: Pasteurized autologous bone graft in surgery for bone and soft tissue sarcoma. Clin Orthop Relat Res 2004; 419: 258-266.
5. Taki J, Inaki A, Wakabayashi H, et al.: Early prediction of histopathological tumor response to preoperative chemotherapy by Tc-99m MIBI imaging in bone and soft tissue sarcomas. Clin Nucl Med 2010; 35: 154-159.
6. Taki J, Sumiya H, Tsuchiya H, et al.: Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy. J Nucl Med 1997; 38: 501-506.
7. Taki J, Higuchi T, Sumiya H, et al.: Prediction of final tumor response to preoperative chemotherapy by Tc-99m MIBI imaging at the middle of chemotherapy in malignant bone and soft tissue tumors: Comparison with Tl-201 imaging. J Orthop Res 2008; 26: 411-418.
8. Miwa S, Shirai T, Taki J, et al.: Use of 99mTc-MIBI scintigraphy in the evaluation of the response to chemotherapy for osteosarcoma: Comparison with 201Tl scintigraphy and angiography. Int J Clin Oncol 2011; 16: 373-378.
9. Ueda T, Naka N, Araki N, et al.: Validation of radiographic response evaluation criteria of preoperative chemotherapy for bone and soft tissue sarcomas: Japanese Orthopaedic Association Committee on Musculoskeletal Tumors Cooperative Study. J Orhop Sci 2008; 13: 304-312.
10. van der Woude HJ, Bloem JL, Verstraete KL, et al.: Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy; value of dynamic MR imaging in detecting viable tumor before surgery. AJR Am J Roentgenol 1995; 165: 593-598.
11. Ramanna L, Waxman A, Binney G, et al.: Thallium-201 scintigraphy in bone sarcoma: Comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response. J Nucl Med 1990; 31: 567-572.
12. Rosen G, Loren GJ, Brien EW, et al.: Serial thallium-201 scintigraphy in osteosarcoma. Correlation with tumor necrosis after after preoperative chemotherapy. Clin Orthop Rel Res 1993; 293: 302-306.
13. Lin J, Leung W, Ho SK, et al.: Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcoma. Eur J Nucl Med 1995; 22: 553-555.
14. 99mTc-MIBI scintigraphy in the evaluation of the response of osteosarcoma to chemotherapy. Eur J Nucl Med 1997; 24: 511-515.
15. Kunisada T, Ozaki T, Kawai A, et al.: Imaging assessment of the response of osteosarcoma patients to preoperative chemotherapy. Angiography compared with thallium-201 scintigraphy. Cancer 1999; 86: 949-956.
16. Kostakoglu L, Panicek DM, Divgi CR, et al.: Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcomas. Eur J Nucl Med 1995; 22: 1232-1237.
17. 18F-FDG PET and MRI. J Nucl Med 2009; 9: 1435-1440.
18. Tsuchiya H, Tomita K, Mori Y, et al.: Caffeine-assisted chemotherapy and minimized tumor excision for non metastatic osteosarcoma. Anticancer Res 1998; 18: 657-666.
19. Tsuchiya H, Tomita K, Yamamoto N, et al.: Caffeine potentiated chemotherapy and conservative surgery for high grade soft tissue sarcomas. Anticancer Res 1998; 18: 3651-3656.
20. Takeuchi A, Tsuchiya H, Yamamoto N, et al.: Caffeine potentiated chemotherapy for patients with high-grade soft tissue sarcoma: Long-term clinical outcome. Anticancer Res 2007; 27: 3489-3496.
21. Miwa S, Kitamura S, Shirai T, et al.: Desmoplastic small round cell tumour successfully treated with caffeine-assisted chemotherapy: A case report and review of the literature. Anticancer Res 2010; 30: 3769-3774.
22. Miwa S, Sugimoto N, Shirai T, et al.: Caffeine activates tumor suppressor PTEN in sarcoma cells. Int J Oncol 2011; 36: 465-472.
23. Rosen G, Caparros B, Huvos A, et al.: Preoperative chemotherapy for osteogenic osteosarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 1982; 49: 1221-1230.
24. Therasse P, Arbuck SG, Eisenhauer EA, et al.: New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000; 92: 205-216.
25. Davis AM, Bell RS, Goodwin PJ,: Prognostic factors in osteosarcoma: A critical review. J Clin Oncol 1994; 12: 423-431.
26. Bacci G, Springfield D, Capanna R, et al.: Neoadjuvant chemotherapy for osteosarcoma of the extremity. Clin Orthop Relat Res 1987; 224: 268-276.
27. Winkler K, Bielack S, Delling G, et al.: Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86). Cancer 1990; 66: 1703-1710.
28. Hudson M, Jaffe MR, Jaffe N, et al.: Pediatric osteosarcoma: therapeutic strategies, results, and prognostic factors derived from a 10-year experience. J Clin Oncol 1990; 8: 1988-1997.
29. Furukawa T, Kubota T, Hoffman RM,: Clinical applications of the histoculture drug response assay. Clin Cancer Res 1995; 1: 305-311.
30. Singh B, Li R, Xu L, et al.: Prediction of survival in patients with head and neck cancer using the histoculture drug response assay. Head Neck 2002; 24: 437-442.
31. Kubota T, Sasano N, Abe O, et al.: Potential of the histoculture drug-response assay to contribute to cancer patient survival. Clin Cancer Res 1995; 1: 1537-1543.
32. Vescio RA, Redfern CH, Nelson TJ,: In vivo-like drug responses of human tumors growing in three-dimensional gel-supported primary culture. Proc Natl Acad Sci USA 1987; 84: 5029-5033.
33. Freeman AE, Hoffman RM,: In vivo-like growth of human tumors in vitro. Proc Natl Acad Sci USA 1986; 83: 2694-2698.
34. Beanlands RS, Dawood F, Wen WH, et al.: Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability?. Circulation 1990; 82: 1802-1814.
35. Carvalho PA, Chiu ML, Kronauge JF, et al.: Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. J Nucl Med 1992; 33: 1516-1522.
36. Piwnica-Worms D, Kronauge JF, Chiu ML,: Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium in cultured chick myocardial cells; mitochondrial and plasma membrane potential dependence. Circulation 1990; 82: 1826-1838.
37. Piwnica-Worms D, Chiu ML, Budding M, et al.: Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 1993; 53: 977-984.